News From February 2022

Published on 03/02/2022

5 min read

Newsletter updates for February 2022
News from SOPHiA GENETICS – February 2022

alt_text

Newsletter – February 2022

New Deep Learning Capabilities for HRD Detection

SOPHiA DDM HRD Solution combines information from germline and somatic HRR mutations with a measure of genomic scarring. Accelerate and empower your clinical cancer research decisions with cost-effective, reliable, and timely in-house results.

Rare Disease Day Quiz

Test your knowledge of rare diseases and win a chance to choose a charity to receive a donation!

Continuing to crack the mitochondrial genetic code

What are mitochondria, why do they cause disease, and how can we analyze their genome? Learn more in our new Science Hub article. 

Hiroshima University to Utilize Myeloid Plus Solution

Hiroshima University aimed to establish a framework where the NGS-based testing would become a routine part of clinical diagnosis for myeloid neoplasms.

RNAtarget Technology

Advanced customizable RNA-based sequencing approach that offers a single convenient workflow with confident novel fusion detection, while also providing ability to detect SNV/Indels and expression changes.

Upcoming events


 

ACMG – Nashville
March 23, 2022 – March 26, 2022
In-person, Virtual


AACR – New Orleans
April 8, 2022 – April 12, 2022
In-person, Virtual


ASCO 2022 – Chicago
June 3, 2022 – June 7, 2022
In-person, Virtual

In The News


 

GenomeWeb

SOPHiA GENETICS, AstraZeneca Team on In-House HRD Testing in Ovarian Cancer
 

TechRound

Pandemic Predictions: What Will COVID-19 Look Like in 2022?

The Bio Report

Making Data-Driven Medicine a Reality

arrow arrow arrow arrow arrow

DISCLAIMER

The information included in this document has been prepared for and is intended for viewing by a global audience. This document contains information about products and services which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indication for use. Please consult local sales representative.

 

alt_text

pink dots icon

Related Posts

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.